Evidence map›Paper›PMID 40483266›Full record

ReviewNPJ breast cancer2025

Inflammatory breast cancer, best practice in the community setting.

Yoko Takahashi, Nithya Sridhar, Toshiaki Iwase, Ashley Marumoto, Jami Fukui, Aiesha Pradhan, Yee Chung Cheng, Naoto T Ueno

Abstract readReview
In one paragraph

Review in NPJ breast cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yoko TakahashiUniversity of Hawai'i Cancer Center Inflammatory Breast Cancer Clinic and Research Program, Honolulu, HI, USA.
Nithya SridharDepartment of Internal Medicine, Baylor College of Medicine, Houston, TX, USA.
Toshiaki IwaseTranslational and Clinical Research Program, University of Hawai'i Cancer Center, Honolulu, HI, USA.
Ashley MarumotoUniversity of Hawai'i Cancer Center Inflammatory Breast Cancer Clinic and Research Program, Honolulu, HI, USA.
Jami FukuiUniversity of Hawai'i Cancer Center Inflammatory Breast Cancer Clinic and Research Program, Honolulu, HI, USA.
Aiesha PradhanDepartment of Science and Technology Studies, Cornell University, Ithaca, NY, USA.
Yee Chung ChengDivision of Hematology and Oncology, Department of Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI, USA.
Naoto T UenoUniversity of Hawai'i Cancer Center Inflammatory Breast Cancer Clinic and Research Program, Honolulu, HI, USA. nueno@cc.hawaii.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer typically diagnosed at advanced stages. Although many cases initially respond to conventional therapies, IBC remains refractory, with high risk of recurrence due to early dissemination, tumor heterogeneity, and complex microenvironmental factors. Despite advancements in treatment, IBC poses unique challenges, particularly in community healthcare settings, where implementation of current guidelines is often limited by disease complexity and evidence gaps. Multidisciplinary care is essential and should include education on therapeutic options, lymphedema management, financial navigations, and ongoing support. To support diagnostic consistency, a consensus-driven IBC Scoring System has been developed to help clinicians identify IBC more accurately using clinical features This paper reviews best practices for managing IBC in community settings, emphasizing practical, multidisciplinary strategies that improve outcomes and presenting a framework aligns with the realities of community healthcare to ensure patients receive the highest possible standard of care.

Identifiers

PMID40483266
PMCPMC12145426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.